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Key points
† This study addresses the
uptake of lactate after
central venous or portal
infusion in pigs.
† Lactate metabolism is
important for
understanding the
haemodynamics and
regional blood flow of
sepsis.
† Lactate infused into the
portal vein is removed
mainly by the liver,
whereas central venous
infusion results in less
uptake by the liver.
Background. The rate of extra-hepatic lactate production and the route of influx of lactate
to the liver may influence both hepatic and extra-hepatic lactate exchange. We assessed
the dose–response of hepatic and extra-hepatic lactate exchange during portal and
central venous lactate infusion.
Methods. Eighteen pigs randomly received either portal (n¼5) or central venous (n¼7)
lactate infusion or saline (n¼6). Sodium lactate was infused at 33, 66, 99, and 133 mmol
kg21 min21 for 20 min each. Systemic and regional abdominal blood flows and plasma
lactate were measured at 20 min intervals until 1 h post-infusion, and regional lactate
exchange was calculated (area under lactate uptake–time curve).
Results. Total hepatic lactate uptake [median (95% confidence interval)] during the
experimental protocol (140 min) was higher during portal [8198 (5487–12 798) mmol
kg21] than during central venous lactate infusion [4530 (3903–5514) mmol kg21,
P,0.05]. At a similar hepatic lactate delivery (400 mmol kg21 min21), hepatic lactate
uptake [mean and standard deviation (SD)] was higher during portal [118 (SD 55) mmol
kg21 min21] than during central venous lactate infusion [44 (12) mmol kg21 min21,
P,0.05]. Time courses of arterial lactate concentrations and lactate uptake at other
measured regions were similar in both groups.
Conclusions. Higher hepatic lactate uptake during portal compared with central venous
lactate infusion at a similar total hepatic lactate influx underlines the role of portal vein
lactate concentration in total hepatic lactate uptake capacity. Arterial lactate
concentration does not depend on the site of lactate infusion. At higher arterial lactate
concentrations, all regions participated in lactate uptake.
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Hyperlactataemia as a result of insufficient tissue perfusion
is frequently seen in critically ill patients and in patients
undergoing emergency procedures. Although the
measurement of blood lactate levels is widely used to
assess the adequacy of tissue perfusion, the interpretation
of elevated blood lactate levels is limited by several con-
founding factors, such as acute changes in acid–base
balance, inter-organ substrate flux, peripheral and visceral
tissue perfusion, and hepatic lactate uptake.
Lactate kinetics in the hepato-splanchnic region are
difficult to assess in man because of lack of access to the
portal vein for blood sampling, complex hepatic blood flow
regulation, and a large reserve of the liver to extract lactate.
For example, prolonged mesenteric ischaemia does not
necessarily result in systemic hyperlactataemia due to
increased hepatic lactate uptake and blood flow redistribution
between superior mesenteric and coeliac trunk perfusion.1
Hepatic lactate uptake is a linear function of prehepatic
lactate concentrations.2–5 In sheep, the hepatic uptake
during lactate infusion is a saturable process with
second-order kinetics.6 However, several factors modify this
relationship, among them blood flow,7 substrate availability
(e.g. glucose),8 pH,7 9 and sepsis.10 Interestingly, reduction
in the size of healthy liver parenchyma does not lead to
hyperlactataemia in patients after major hepatectomy,
demonstrating large liver functional reserve with maintained
lactate metabolism.11
The ability to metabolize lactate differs among various
extra-hepatic organs.12–17 The kidney removes 20–30% of
an exogenous lactate load.6 18–20 Muscle tissues are
British Journal of Anaesthesia 105 (5): 627–34 (2010)
Advance Access publication 6 August 2010 . doi:10.1093/bja/aeq214
& The Author [2010]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournal.org
responsible for the disposal of roughly one-fifth of the lactate
load during sodium lactate infusion in healthy volunteers21
and lactic acid infusion in dogs.22 Lactate metabolism also
occurs in the adipose tissue23 and in portal drained
viscera.6 At arterial lactate concentrations .9 mmol litre21,
peripheral tissues remove more lactate than the liver.6
The effect of the site of lactate infusion (or production) on
local and remote organ lactate uptake, and the resulting sys-
temic lactate appearance, has not been investigated. We
hypothesized that (i) arterial lactate concentration deter-
mines the lactate exchange in extra-hepatic organs and (ii)
at a similar total hepatic lactate influx, hepatic lactate
uptake is enhanced when lactate is infused in the portal
vein when compared with the central vein. According to
this hypothesis, all organs will participate in lactate uptake
when arterial lactate increases. Depending on their effective
capability to metabolize lactate, the organs will however
release some of the lactate load when arterial lactate con-
centrations decrease later. Moreover, a given lactate load
should result in lower arterial lactate concentrations when
originating from the splanchnic region when compared
with other regions. Consequently, prehepatic lactate pro-
duction would be more difficult to detect.
Methods
The study was performed in accordance with the National
Institutes of Health guidelines for the care and use of exper-
imental animals and with the approval of the Institutional
Animal Care and Use Committee of the University of
Kuopio, Finland. The experimental setup has been described
previously in detail.1 24 Briefly, animals were premedicated
with i.m. atropine (0.05 mg kg21) and azaperone (8 mg kg21).
Subsequently, thiopental (5–15 mg kg21) was administered
via a cannulated ear vein for tracheal intubation. Anaesthe-
sia was maintained with thiopental (5 mg kg21 h21) and
fentanyl (30 mg kg21 h21) until the end of the surgical
procedure. After surgery and until the end of the experiment,
anaesthesia was maintained using thiopental (5 mg kg21 h21)
and fentanyl (5 mg kg21 h21). This anaesthesia regimen was
sufficient to suppress any movements and reactions of
physiological parameters to surgery and post-surgical
manipulations and no neuromuscular blocking agents were
used. All animals were ventilated by a volume-controlled
ventilator without PEEP. FIO2 was adjusted to keep PaO2
levels above 13.3 kPa. Tidal volume was set to 10 ml kg21.
PaCO2 was kept between 4.5 and 5.5 kPa by adjusting
minute ventilation. Monitoring and animal preparation are
described fully in the Supplementary material. Briefly, anaes-
thetized animals underwent laparotomy and ultrasound
transit-time flow probes (Transonic Systems Inc., Ithaca,
NY, USA) were placed around the coeliac trunk, superior
mesenteric, common hepatic, right kidney and femoral
arteries, and portal vein, and catheters for blood sampling
were inserted into the hepatic, mesenteric, right kidney,
femoral, and distal portal veins, and for lactate infusion
into proximal portal vein.
Experimental protocol
Eighteen female pigs [36 (5) kg body weight] were deprived
of food, but not water, for 12 h before the experiment.
After surgery, haemodynamics were allowed to stabilize for
60 min. Animals were randomly allocated to three groups:
portal vein infusion group (PV), central vein infusion group
(CV), and normal saline infusion group (control). One exper-
iment was repeated due to technical problems with the
portal vein transit-time flow probe in an animal from the
PV group. By mistake, in the repeated experiment, lactate
infusion was administered via the central vein catheter.
This resulted ultimately in an uneven number of animals in
the three experimental groups: PV, n¼5; CV, n¼7; and
control, n¼6.
During a period of 80 min, the animals in the CV and PV
groups received infusions of 2 mol litre21 sodium lactate
into the central vein and distal portal veins, respectively,
and 0.9% saline in the respective other vessel, whereas all
animals in the control group received 0.9% saline in both
vessels equally. Sodium lactate was infused in a stepwise
manner at rates of 1, 2, 3, and 4 ml kg21 h21, with each
infusion lasting 20 min. Saline infusions were administered
at the same rates. At baseline (time0), and after each 20
min step (time20 to time140), systemic and regional
blood flows were measured, and blood samples were
drawn from radial and pulmonary arteries and from
femoral, renal, mesenteric, proximal portal, and hepatic
veins for blood gas analysis and determination of haemo-
globin and plasma lactate concentrations. The measure-
ments were continued at 20 min intervals for 1 h after
the last step of lactate infusion. At the end of the exper-
iment, the animals were killed with an i.v. overdose of mag-
nesium. Haemodynamic monitoring is described in the
Supplementary material.
Regional blood flow, blood gas, haemoglobin,
and lactate measurements
Ultrasound transit-time flow probes were calibrated in vitro
before recording of the signals (Flowmeters T108 and T208,
Transonic Systems Inc.). Blood samples for the measurement
of haemoglobin, blood gas analysis, and lactate were ana-
lysed immediately after withdrawal. Haemoglobin concen-
trations and oxygen saturations were measured with an
analyzer designed for porcine blood (OSM 3, Radiometer,
Copenhagen, Denmark). Blood gases were analysed at 378C
in a blood gas analyzer (ABL 500, Radiometer). An ampero-
metric enzyme sensor method (YSI 2300 Stat Plusw, YSI
Inc., Yellow Springs, OH, USA) was utilized to measure
plasma lactate. Calculations for regional lactate exchanges
are given in the Supplementary material.
Statistics
Detailed statistics are described in the Supplementary
material. Briefly, differences between groups for normally
distributed variables (Kolmogorov–Smirnov test) were
assessed by analysis of variance (ANOVA) for repeated
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measurements using one dependent variable, one grouping
factor (PV, CV, and controls), and one within-subject factor
(time). In the case of non-normality, differences at baseline
were tested using the Kruskal–Wallis test. Afterwards,
changes over time were evaluated separately in each group
using Friedman’s test. The relationship between arterial
lactate concentration and the various regional lactate
exchanges was explored by linear regression analysis. Data
are presented as mean and standard deviation (SD) or
as median [95% confidence interval (CI)] as appropriate.
Statistical significance was defined as P,0.05.
Results
At baseline (time0), variables were similar in all groups.
Systemic haemodynamics
Cardiac output increased during lactate infusion in the PV
and CV groups, without differences between groups (see Sup-
plementary Table S1).
Regional blood flow
Except for an increase in hepatic arterial blood flow in both
lactate infusion groups, there were no differences between
groups (see Supplementary Table S2).
Blood gases and oxygen transport
Arterial pH and base excess increased in both lactate infusion
groups (P,0.05), whereas arterial and mixed venous oxygen
saturation decreased in these two groups (see Supplemen-
tary Table S3). Systemic oxygen consumption tended to
decrease during lactate infusion in both groups (time–
group interaction, P,0.05).
Tonometry data
Gastric- and jejunal mucosal-arterial PCO2 gradients
decreased during the first 80–100 min in all groups (time
effect for both P,0.05) without between-group differences
(see Supplementary Table S4).
Lactate concentrations and lactate deliveries
Data on regional lactate concentrations and lactate deliv-
eries are presented in Figure 1 and Tables 1 and 2. All con-
centrations remained stable in the control group. Both CV
and PV groups showed an increase in lactate concentration
at all measured locations, with significant differences
between them in the portal vein lactate concentrations at
80 min of lactate infusion and in the hepatic vein lactate
concentrations at 80 min of lactate infusion. In both CV
and PV groups, lactate deliveries increased steadily during
the infusion phase and decreased afterwards, whereas the
control group remained stable. A statistically significant
difference between CV and PV was found for portal
lactate delivery at 20, 60, and 80 min of lactate infusion
(all P,0.05).
Total lactate uptake
During the whole experiment (140 min), the total hepatic
lactate uptake was higher in PV [8198 (5487–12 798) mmol
kg21] compared with CV [4530 (3903–5514) mmol kg21,
P,0.05].
Lactate exchange
Regional lactate exchanges are shown in Figure 2. During
lactate infusion, three distinct patterns were present: in
femoral and mesenteric regions, lactate exchange increased
during infusion and returned to baseline immediately after
lactate infusion was stopped. In these regions, there were
no differences between the CV and PV groups. In the liver
and kidney, lactate exchange continued to be positive after
the infusion had been stopped, and returned only gradually
to baseline during the subsequent 60 min. Hepatic lactate
exchange (uptake) was significantly greater in PV when com-
pared with CV. Pulmonary lactate exchange was highly vari-
able and increased only after lactate infusion had been
stopped.
Hepatic lactate exchange in relation to delivery is shown
in Figure 3. There were significant differences between the
CV and the PV groups: during central vein infusion, hepatic
lactate exchange reached a plateau at an infusion speed of
99 mmol kg21 min21. During portal vein infusion, hepatic
lactate exchange continued to increase when 133 mmol
lactate kg21 min21 was infused, and reached a maximum
which was more than three times as high as during central
vein lactate infusion. Moreover, when lactate infusion was
stopped, hepatic lactate exchange decreased rapidly, and
reached smaller values when compared with similar lactate
delivery rates during lactate infusion.
The relationships between arterial lactate concentration
and regional lactate exchanges are shown in the Supplemen-
tary Figures S1–4. Significant correlations were found for all
regions and all lactate infusion groups except the kidney
during central venous lactate infusion.
Discussion
The main finding of this study is a significantly higher hepatic
lactate uptake during portal vein lactate infusion than during
central vein infusion, even with similar total hepatic lactate
delivery rates. Throughout the observation period, in addition
to baseline lactate exchange, an amount equalling the total
infused lactate was taken up in the liver in the PV group vs
50% in the CV group. In our model, maximal measured
hepatic lactate uptake in the PV group was 127 mmol kg21
min21, which is higher than maximal hepatic lactate
uptake during central vein infusion in sheep (95 mmol kg21
min21).6 Conceptually, the higher hepatic lactate uptake in
the PV vs the CV group in our study can result from either
higher hepatic blood flow or higher portal venous lactate
concentrations.
It has been demonstrated that hepatic lactate
metabolism is flow-dependent.25 However, portal venous
blood flows were similar in both groups in our study,
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and hepatic arterial flows were higher in the central
infusion group, suggesting that the portal venous lactate
concentration was the main determinant in the presence
of normal liver blood flow. Portal lactate concentration
is also an important determinant of hepatic
lactate uptake in situations where increased hepatic
lactate influx is the result of mesenteric ischaemia.1
However, during mesenteric ischaemia, hepatic arterial
blood flow increases; the so-called hepatic arterial buffer
response.26 Whether an increased hepatic arterial blood
flow helps to extract lactate delivered by the portal route
is not known.
At the highest lactate infusion rate, the liver remained
the predominant site of lactate uptake: the hepatic,
femoral, and mesenteric regions contributed 74%, 13%,
and 5% (portal infusion) and 66%, 22%, and 7% (central
infusion), respectively, to total lactate uptake in the
measured regions. This is in agreement with other studies
measuring prehepatic lactate removal in sheep6 and
lactate uptake in the muscle tissue in healthy volunteers.21
Since we did not infuse higher lactate concentrations, we
are unable to confirm the findings of Naylor and col-
leagues6 that extra-splanchnic tissues extract more
lactate than the liver at higher lactate delivery rates. In
patients, dogs, and rats, the kidney was shown to remove
20–30% of lactate load.6 18–20 Since we measured the
flow only in one of several kidney arteries, our renal
lactate uptakes (5–8% of total lactate uptake in the
measured regions) clearly underestimate the contribution
of the kidneys to total lactate clearance.
Whereas lactate exchange decreased only gradually in
the liver and kidney after the lactate infusion had been
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Fig 1 Lactate levels and deliveries to the right kidney and the portal vein for pigs infused with lactate in the pulmonary artery or portal vein, or
with saline. Lactate (2 mol litre21) and saline were infused in four consecutive steps (1, 2, 3, and 4 ml kg21 h21) for 20 min each. Median and
95% CI. *Difference between the two lactate infused groups (P,0.05).
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Table 1 Lactate concentrations in pigs infused with lactate (CV, central vein infusion group; PV, portal vein infusion group) or saline (control). Values are mean (SD) or median (95% CI).
Statistically significant differences between CV and PV were detected only for the hepatic vein at the 80th minute
Parameter Time Group P-value
(time)
P-value
(time3group)Baseline Infusion phase Post-infusion phase
0 20 40 60 80 100 120 140
Lactate radial artery
(mmol litre21)
CV 0.9 (0.3) 2.6 (1.0) 5.8 (0.8) 9.3 (1.1) 13.3 (1.8) 6.7 (1.0) 4.3 (0.6) 2.9 (0.5) ,0.05 ,0.05
PV 0.8 (0.1) 2.6 (0.1) 5.4 (0.4) 8.6 (0.8) 13.4 (2.0) 7.6 (2.0) 5.3 (1.9) 4.1 (1.7)
Control 0.9 (0.3) 0.8 (0.2) 0.8 (0.2) 0.7 (0.2) 0.7 (0.1) 0.7 (0.1) 0.7 (0.1) 0.7 (0.2)
Lactate femoral vein
(mmol litre21)
CV 1.2 (0.3) 2.3 (0.7) 4.6 (0.8) 7.8 (0.9) 11.5 (1.6) 7.4 (1.1) 5.0 (0.6) 3.6 (0.5) ,0.05 ,0.05
PV 1.0 (0.2) 2.2 (0.2) 4.3 (0.5) 7.1 (1.0) 11.3 (1.4) 8.3 (1.8) 6.2 (1.9) 4.8 (1.6)
Control 1.1 (0.3) 1.0 (0.3) 1.0 (0.3) 1.0 (0.2) 0.9 (0.2) 0.9 (0.2) 0.9 (0.2) 1.0 (0.2)
Lactate hepatic vein
(mmol litre21)
CV 0.3 (0.2–0.6) 1.7 (0.8–2.3) 3.8 (3.3–5.0) 6.9 (6.2–8.3) 11.7 (9.6–13) 5.0 (4.4–5.9) 3.4 (2.6–3.7) 1.9 (1.6–2.5) ,0.05
PV 0.5 (0.3–0.6) 3.1 (1.8–3.8) 6.9 (4.1–8.1) 10 (9–11) 16 (13–18) 5.7 (2.7–9.3) 3.4 (1.4–6.7) 2.6 (0.8–5.4) ,0.05
Control 0.4 (0.2–0.6) 0.4 (0.2–0.6) 0.4 (0.2–0.5) 0.3 (0.2–0.5) 0.3 (0.2–0.4) 0.3 (0.2–0.4) 0.3 (0.2–0.4) 0.3 (0.2–0.4) NS
Lactate mesentric vein
(mmol litre21)
CV 1.0 (0.3) 2.7 (1.0) 5.5 (1.0) 9.0 (1.2) 12.7 (1.8) 6.7 (1.0) 4.5 (0.7) 3.1 (0.6) ,0.05 ,0.05
PV 1.0 (0.2) 2.6 (0.3) 4.9 (0.9) 8.3 (1.0) 12.8 (2.0) 7.9 (2.4) 6.0 (2.3) 4.4 (1.8)
Control 1.0 (0.3) 1.0 (0.3) 1.0 (0.3) 0.9 (0.2) 0.9 (0.2) 0.9 (0.2) 0.9 (0.2) 0.9 (0.2)
Mixed venous lactate
(mmol litre21)
CV 0.7 (0.6–1.1) 2.8 (1.8–3.6) 5.7 (4.8–6.8) 9.1 (8.4–10.5) 14 (12–15) 6.2 (5.8–7.2) 4.2 (3.6–4.9) 2.9 (2.4–3.5) ,0.05
PV 0.8 (0.6–1.0) 2.5 (2.3–2.7) 5.3 (4.8–5.8) 8.5 (7.6–9.6) 12 (11–16) 7.1 (4.7–9.7) 4.8 (2.9–7.5) 3.5 (1.9–5.9) ,0.05
Control 0.9 (0.6–1.1) 0.9 (0.6–1.0) 0.7 (0.5–0.9) 0.7 (0.5–0.9) 0.6 (0.5–0.8) 0.6 (0.5–0.8) 0.6 (0.5–0.8) 0.7 (0.5–0.8) NS
Systemic lactate
appearance (mmol
litre21)
CV 2.1 (0.9) 7.4 (3.2) 18.7 (5.3) 33.1 (5.4) 52.2 (9.8) 21.9 (5.4) 14.2 (3.9) 8.3 (5.2) ,0.05 ,0.05
PV 2.2 (1.0) 6.7 (2.6) 15.8 (6.3) 28.7 (10.7) 51.1 (15.4) 22.9 (8.0) 14.7 (6.7) 10.4 (4.8)
Control 2.5 (0.6) 2.4 (0.5) 2.2 (0.4) 2.0 (0.4) 1.8 (0.3) 1.8 (0.4) 1.9 (0.4) 1.9 (0.6)
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stopped, transient lactate uptake during lactate infusion in
mesenteric and femoral regions turned to net lactate
release very quickly. This is likely to reflect partial storage
of lactate and later release, rather than active metabolism
in these regions. The post-infusion changes in the mesenteric
region did not differ significantly among the three groups
examined. One possibility is a higher ‘lactate storage’
capacity of the mesenteric when compared with the
femoral region, with later onset of lactate release. Since
blood sampling was stopped at 140 min, we have no data
to support this hypothesis.
At the highest lactate infusion rate, total apparent tissue
lactate uptake (the sum of uptakes in the measured
regions) was much higher in the PV group (173 mmol kg21
min21) when compared with the CV group (68 mmol kg21
min21). Consequently, a significant part of the lactate
infused into the central vein must have been removed by
other, unmeasured tissues (e.g. brain, heart, and other skel-
etal muscles). Our estimate on lung lactate exchange should
be interpreted with caution: the mixed venous–arterial
lactate gradient is small, even during central venous infusion.
Hence, small measurement errors may induce large vari-
ations in calculated lactate uptake, and up to five serial
samples may be necessary for a reliable estimate of lung
lactate exchange.27 This was not done in the present study,
both for technical reasons and due to the blood volume
needed for the analyses.
We interpret the increasing systemic oxygen consumption
during lactate infusion as the consequence of increased
lactate metabolism, and the decreasing arterial oxygen sat-
uration as a consequence of increasing systemic oxygen
extraction and intra-pulmonary shunt.28
This study has limitations. First, lactate was infused and
not produced by tissue hypoxia. Accordingly, effects of
changes in systemic and regional blood flows, acidosis,
and/or inflammation on regional lactate metabolism were
not taken into account.7–10 Nevertheless, effects of regional
lactate exchange during mesenteric ischaemia1 and sys-
temic hypoperfusion25 have been addressed. Secondly,
since no tracers were used, the relationship between
lactate uptake, storage, metabolism, and release, and the
extent to which all of these processes occurred in the
various tissues, cannot be addressed.
In summary, this study demonstrates that portal vein
lactate concentration is an important determinant of
hepatic lactate uptake. However, time course and magnitude
of increases in arterial plasma lactate concentrations as a
result of regional lactate infusion are not dependent on the
site of lactate infusion. Besides several organs such as the
liver or the kidney that contribute to lactate extraction,
other parts of the body, such as the mesenteric region or
the legs, may also have an important function in removing
lactate from the blood. Our data suggest that in these
regions, the arterial lactate concentration is the main deter-
minant of tissue lactate uptake. If lactate is infused into a
central vein, extra-hepatic tissues extract more lactate
than the liver.
Ta
bl
e
2
La
ct
at
e
d
el
iv
er
y
in
pi
gs
in
fu
se
d
w
it
h
la
ct
at
e
(C
V
,c
en
tr
al
ve
in
in
fu
si
on
gr
ou
p;
PV
,p
or
ta
lv
ei
n
in
fu
si
on
gr
ou
p)
or
sa
lin
e
(c
on
tr
ol
).
Va
lu
es
ar
e
m
ea
n
(S
D
)
or
m
ed
ia
n
(9
5%
C
I)
Pa
ra
m
et
er
Ti
m
e
G
ro
up
P-
va
lu
e
(t
im
e)
P-
va
lu
e
(t
im
e
3
gr
ou
p)
B
as
el
in
e
In
fu
si
on
ph
as
e
Po
st
-i
nf
us
io
n
ph
as
e
0
20
40
60
80
10
0
12
0
14
0
Fe
m
or
al
la
ct
at
e
d
el
iv
er
y
(m
m
ol
kg
2
1
m
in
2
1
)
C
V
2.
8
(1
.6
)
11
.9
(9
.4
)
26
.1
(1
7.
3)
48
.3
(2
7.
7)
63
.2
(4
0.
8)
18
.6
(7
.7
)
13
.4
(4
.9
)
9.
5
(3
.8
)
,
0.
05
,
0.
05
PV
3.
3
(1
.3
)
10
.8
(5
.3
)
26
.1
(1
4.
6)
43
.6
(2
4.
8)
79
.8
(4
0.
0)
33
.2
(1
7.
0)
20
.8
(1
0.
3)
16
.6
(1
0.
1)
Co
n
tr
ol
2.
58
(0
.7
8)
2.
47
(0
.9
1)
2.
50
(0
64
)
2.
17
(0
.8
1)
1.
97
(0
.8
5)
1.
98
(0
.9
0)
1.
9
(0
.9
)
1.
9
(1
.0
)
H
ep
at
ic
ar
te
ri
al
la
ct
at
e
d
el
iv
er
y
(m
m
ol
kg
2
1
m
in
2
1
)
C
V
0.
9
(0
.6
–
2.
0)
5.
5
(3
.2
–
6.
2)
14
(1
0
–
25
)
33
(1
7
–
61
)
76
(4
7
–
11
7)
41
(2
1
–
56
)
26
(1
4
–
31
)
14
(6
–
24
)
,
0.
05
PV
1.
1
(0
.4
–
2.
8)
8.
0
(4
.7
–
9.
8)
18
(1
4
–
26
)
40
(3
2
–
51
)
73
(5
1
–
10
3)
41
(2
4
–
59
)
30
(1
2
–
44
)
22
(9
.8
–
28
)
,
0.
05
Co
n
tr
ol
1.
5
(0
.7
–
2.
9)
1.
7
(0
.6
–
3.
2)
2.
0
(0
.7
–
3.
2)
1.
8
(0
.6
–
3.
4)
2.
3
(0
.9
–
3.
6)
2.
0
(1
.0
–
3.
4)
1.
9
(1
.1
–
3.
4)
1.
9
(0
.9
–
3.
6)
N
S
M
es
en
te
ri
c
la
ct
at
e
d
el
iv
er
y
(m
m
ol
kg
2
1
m
in
2
1
)
C
V
8.
6
(2
.5
)
28
(1
2)
65
(1
8)
11
3
(2
9)
16
2
(4
2)
69
(1
6)
47
(1
1)
33
(1
2)
,
0.
05
,
0.
05
PV
11
(3
.4
)
34
(6
.3
)
74
(1
5)
12
7
(2
5)
20
9
(3
9)
10
7
(3
5)
75
(3
4)
54
(2
5)
Co
n
tr
ol
12
(4
.8
)
13
(4
.1
)
11
.7
(3
.2
)
11
.1
(3
.5
)
10
(3
.5
)
10
(3
.4
)
11
(3
.9
)
10
(3
.2
)
Pu
lm
on
ar
y
la
ct
at
e
d
el
iv
er
y
(m
m
ol
kg
2
1
m
in
2
1
)
C
V
53
(1
9)
20
8
(8
0)
49
4
(9
5)
89
9
(1
29
)
13
90
(9
7)
56
6
(8
1)
37
4
(6
6)
22
0
(1
22
)
,
0.
05
,
0.
05
PV
63
(2
1)
19
4
(4
5)
47
2
(1
48
)
86
7
(2
54
)
15
36
(4
29
)
68
6
(2
86
)
44
8
(2
11
)
31
4
(1
59
)
Co
n
tr
ol
68
(1
4)
67
(1
8)
61
(1
2)
58
(1
5)
51
(1
1)
51
(1
4)
52
(1
3)
52
(1
5)
BJA Barthelmes et al.
632
Time (min)
Femoral lactate exchange
Pulmonary lactate exchange Renal lactate exchange
Mesenteric lactate exchangeHepatic lactate exchange
0
–10
–5
0
5
10
15
–60
–20
–40
0
20
60
40
80
–50
0
50
100
150
200
–20
–10
0
10
20
–5
5
0
10
15
20 40 60 80 100 120 140
Time (min)
0 20 40 60 80 100 120 140
Time (min)
0 20 40 60 80 100 120 140
Time (min)
0 20 40 60 80 100 120 140
Time (min)
0 20 40 60 80 100 120 140
Central infusion group
Control group
Portal infusion group
La
ct
at
e 
ex
ch
an
ge
 (µ
m
o
l k
g–
1  
m
in
–
1 )
La
ct
at
e 
ex
ch
an
ge
 (µ
m
o
l k
g–
1  
m
in
–
1 )
La
ct
at
e 
ex
ch
an
ge
 (µ
m
o
l k
g–
1  
m
in
–
1 )
La
ct
at
e 
ex
ch
an
ge
 (µ
m
o
l k
g–
1  
m
in
–
1 )
La
ct
at
e 
ex
ch
an
ge
 (µ
m
o
l k
g–
1  
m
in
–
1 )
Fig 2 Femoral, hepatic, mesenteric, pulmonary, and renal lactate exchange in pigs infused with lactate in the pulmonary artery or portal vein,
or with saline (circle). Lactate (2 mol litre21) and saline were infused in four consecutive steps (1, 2, 3, and 4 ml kg21 h21) for 20 min each.
Median and 95% CI. *Difference between the two lactate infused groups (P,0.05).
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Fig 3 Total hepatic lactate exchange vs hepatic lactate delivery in pigs infused with lactate in the pulmonary artery (CV) or portal vein (PV)
during and after infusion. Mean (1 SD). The difference in lactate exchange between CV and PV was significantly different (P,0.05).
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